Esophageal Multisegmented FCSEMS for Malignant Strictures — EATERS  

Oesophageal Cancer Clinical Trial

Official title: EsophageAl mulTisegmented Fully covERed Self-expandable Metal Stent for Malignant Strictures: a Safety and Feasibility Study (EATERS Study)

Status Terminated

Clinical Trial Summary

Objective: To assess the safety and feasibility of the implementation of the esophageal multisegmented fully covered self-expandable metal stent (SEMS) for the palliation of patients with malignant dysphagia.

Study design: Prospective observational nonrandomized clinical study.

Study population: A total of 30 patients with malignant dysphagia will be included. Sample size calculation does not apply for this type of study.

Intervention: All patients will be treated with the esophageal multisegmented fully covered SEMS.

Primary end points:

• Safety: complications and adverse events during follow-up with special attention to stent migration rates;

• Efficacy: technical success of stent placement.

Secondary end points:

• Recurrent dysphagia including its cause;

• Functional outcome: Ogilvie dysphagia score and WHO performance score (measured at baseline, 2 weeks and every 4 weeks until death/stent removal, or until a maximum of 6 months follow-up);

• Tissue ingrowth or overgrowth (measured endoscopically every endoscopic evaluation during follow-up);

• Pain related to esophageal stent.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Esophageal Stent Stenosis
• Oesophageal Cancer

• NCT number: NCT04415463
• Study type: Interventional
• Source: Radboud University Medical Center
• Status: Terminated
• Phase: N/A
• Start date: March 3, 2021
• Completion date: December 1, 2022